Progress in human tumor immunology has recently been accelerated by new assays for antigen-specific cytotoxic T lymphocytes (CTLs). We have used tetrameric MHC class I complexes (tetramers) to study melanoma-specific CTLs both in vivo and in vitro, and have utilized the results to optimize vaccination strategies for patients. Tetramers have provided some of the best evidence to date that CTL responses against melanoma antigens arise spontaneously in patients. However, CTL responses to common ...Expand abstract
- Publication status:
- Publisher copy:
- Copyright date:
The use of HLA class I tetramers to design a vaccination strategy for melanoma patients.
Views and Downloads
If you are the owner of this record, you can report an update to it here: Report update to this record